ArQule, Daiichi-Sankyo sign R&D partnership for cancer compounds

ArQule, Inc and Daiichi Sankyo Co, Ltd announced that they have entered into two agreements that form the basis of a strategic relationship for the development and discovery of novel oncology therapeutics.

The details can be read here.